KalVista Pharmaceuticals, Inc.
USD27.00
+0.00 (+0.00%)
CEO
Benjamin L. Palleiko
IPO Date
2015-04-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$26.98
Prev. Close
$27.00
Day Low
$26.98
Day High
$27.00
52W Low
$9.83
52W High
$27.00
Market Cap
$1.44B
Volume
4.26M
| -3.7 |
| 30 Apr 2024 | FY | 0.0% | 0.0% | -61.3% | -53.8% | 0.04 | 9.90 | -3.3 |
| 30 Apr 2023 | FY | 0.0% | 0.0% | -57.7% | -50.7% | 0.05 | 11.46 | -2.7 |
| 30 Apr 2022 | FY | 0.0% | 0.0% | -44.5% | -40.4% | 0.04 | 16.73 | -3.8 |
| 30 Apr 2021 | FY | 0.0% | 0.0% | -18.0% | -17.0% | 0.02 | 27.04 | -10.3 |
| 30 Apr 2020 | FY | -216.7% | -229.4% | -34.8% | -31.5% | 0.02 | 11.49 | -6.7 |
| 30 Apr 2019 | FY | 99.8% | -129.1% | -21.5% | -17.6% | 0.00 | 6.40 | -16.7 |
| 30 Apr 2018 | FY | 99.8% | -188.3% | -58.0% | -25.7% | 0.01 | 2.56 | -6.3 |
| 30 Apr 2017 | FY | 99.2% | -1236.9% | -59.4% | -54.2% | 0.00 | 11.35 | -3.8 |
| -8.8 |
| 31 Oct 2025 | Q2 | 91.0% | -361.4% | -291.1% | -14.6% | 8.80 | 7.22 | -3.0 |
| 31 Jul 2025 | Q1 | 58.6% | -4214.3% | -147.3% | -27.9% | 0.15 | 5.37 | -3.0 |
| 30 Apr 2025 | Q4 | 0.0% | 0.0% | -54.7% | -20.8% | 0.07 | 5.35 | -3.3 |
| 31 Jan 2025 | Q3 | 0.0% | 0.0% | -33.4% | -17.6% | 0.04 | 10.44 | -2.4 |
| 31 Oct 2024 | Q2 | 0.0% | 0.0% | -31.5% | -26.3% | 0.05 | 6.87 | -2.8 |
| 31 Jul 2024 | Q1 | 0.0% | 0.0% | -23.4% | -20.2% | 0.04 | 8.55 | -4.2 |
| 30 Apr 2024 | Q4 | 0.0% | 0.0% | -21.6% | -19.0% | 0.04 | 9.90 | -2.8 |
| 31 Jan 2024 | Q3 | 0.0% | 0.0% | -32.8% | -25.5% | 0.08 | 5.44 | -4.7 |